Pennant PNTG
NASDAQ PNTG
$39.24 +0.45 (+1.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pennant (PNTG) Gains from Sales and Divestitures (2023 - 2025)

Updated

Pennant's Gains from Sales and Divestitures came in at $51,000 for Q3 2025, compared with -$4,000 a year earlier and down 95.1% from the prior quarter.

Analysis

Pennant (PNTG) Gains from Sales and Divestitures (2023 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Pennant reported Gains from Sales and Divestitures of $1.1 million, up 46.0% year-over-year.

  • The five-year range for quarterly Gains from Sales and Divestitures is -$4,000 (Q3 2024) to $1.05 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn
6 Tenet Healthcare 20.83 Bn 11.98 Bn -
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn
9 Encompass Health 11.82 Bn 12.29 Bn -
10 Pennant 1.37 Bn 1.41 Bn 55.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 51,000.00
Jun 30, 2025 1.05 Mn
Sep 30, 2024 -4,000.00
Mar 31, 2024 755,000.00
Sep 30, 2023 -1,000.00
Jun 30, 2023 -3,000.00
API Access

Pennant Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PNTG&period=max&api_key=YOUR_API_KEY